Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen trometamol injection for hemodynamically significant PDA in preterm neonates
CTR20202663Phase 3Completed
- Sponsor
- Chengdu Yuandong Biological Pharmaceutical
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ibuprofen + trometamol in patent ductus arteriosus (PDA), sponsored by Chengdu Yuandong Biological Pharmaceutical. Started Dec 2020; status: completed.
02
Drugs
ibuprofen + trometamol
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on CTR20202663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202663.